Naoto Azuma

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 182 citations

Diabetes Management, Cardiovascular Disease, Medicine +8

Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis

Teppei Hashimoto, Shigeharu Ueki, Yosuke Kamide et al. · Frontiers in Immunology · 2022 · 55 citations · Full text

Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis

Eriko Kudo-Tanaka, Shiro Ohshima, Masaru Ishii et al. · Clinical Rheumatology · 2007 · 42 citations

Inflammation, Rheumatology, Rheumatoid Disorder +12

Sphingosine 1-phosphate (S1P)/S1P receptor 1 signaling regulates receptor activator of NF-κB ligand (RANKL) expression in rheumatoid arthritis

Harunori Takeshita, Masayasu Kitano, Tsuyoshi Iwasaki et al. · Biochemical and Biophysical Research Communications · 2012 · 37 citations

Immunology, Immune Regulation, Inflammatory Arthritis +16

Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile

Osamu Saiki, Hiroshi Uda, N. Nishimoto et al. · Clinical Immunology · 2004 · 35 citations

Clinical Immunology, Inflammation, Cytokine +9